Global Nitric Oxide Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

This study focuses on the production side and consumption side of Nitric Oxide, presents the global Nitric Oxide market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

In terms of production side, this report researches the Nitric Oxide capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.

In terms of consumption side, this report focuses on the consumption of Nitric Oxide by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Request Sample Copy of this Report @ https://www.qyresearch.com/sample-form/form/709050/global-nitric-oxide-industry-research-report-growth-trends-and-competitive-analysis

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

The Nitric Oxide market was valued at xx Million US$ in 2017 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Nitric Oxide.

Request to view and Download Table of Contents@ https://www.qyresearch.com/index/toc/709050/global-nitric-oxide-industry-research-report-growth-trends-and-competitive-analysis

This report includes the following manufacturers; we can also add the other companies as you want.

Mallinckrodt

Praxair

Air Liquide

Market Segment by Product Type

99.92% Purity

99.99% Purity

Other

Market Segment by Application

ARDS

PPHN

Other Diseases

Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/2af4979d188d2783961ced2deaa6c85b,0,1,Global%20Nitric%20Oxide%20Industry%20Research%20Report%252C%20Growth%20Trends%20and%20Competitive%20Analysis%202018-2025

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

QY Research, INC.
17890 Castleton, Suite 218,
Los Angeles, CA – 91748
USA: +1 6262 952 442
China: +86 1082 945 717
Japan: +81 9038 009 273
India: +91 9766 478 224
Emails – enquiry@qyresearch.com
Web – www.qyresearch.com
Expert News: www.qyresearch.com/expert/list

This release was published on openPR.